Formosa Optical Technology Co (ROCO:5312) ROE %: 7.05% (As of Dec. 2025) — 44% Below Median


ROCO:5312 Formosa Optical Technology Co Ltd ROCO:5312
82 GF Score
Price NT$88.10
GF Value NT$108.56
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Formosa Optical Technology Co ROE %?

Formosa Optical Technology Co ROCO:5312 +0.34% 82 ROE % is 7.05% as of Dec. 2025, which is 44% below its 10-year median of 12.64. GuruFocus rates ROCO:5312 with a GF Score™ of 82/100 and a GF Value™ of NT$108.56 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Formosa Optical Technology Co ranks better than 77.67% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Formosa Optical Technology Co's annualized net income for the quarter that ended in Dec. 2025 was NT$254 Mil. Formosa Optical Technology Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was NT$3,606 Mil. Therefore, Formosa Optical Technology Co's annualized ROE % for the quarter that ended in Dec. 2025 was 7.05%.

The historical rank and industry rank for Formosa Optical Technology Co's ROE % or its related term are showing as below:

ROCO:5312' s ROE % Range Over the Past 10 Years
Min: 6.5   Med: 12.64   Max: 15.8
Current: 11.12

During the past 13 years, Formosa Optical Technology Co's highest ROE % was 15.80%. The lowest was 6.50%. And the median was 12.64%.

ROCO:5312's ROE % is ranked better than
77.67% of 797 companies
in the Medical Devices & Instruments industry
Industry Median: 2.4 vs ROCO:5312: 11.12

Formosa Optical Technology Co  (ROCO:5312) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=254.168/3606.247
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(254.168 / 4507.436)*(4507.436 / 8979.2715)*(8979.2715 / 3606.247)
=Net Margin %*Asset Turnover*Equity Multiplier
=5.64 %*0.502*2.4899
=ROA %*Equity Multiplier
=2.83 %*2.4899
=7.05 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=254.168/3606.247
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (254.168 / 333.608) * (333.608 / 347.124) * (347.124 / 4507.436) * (4507.436 / 8979.2715) * (8979.2715 / 3606.247)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7619 * 0.9611 * 7.7 % * 0.502 * 2.4899
=7.05 %

Note: The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Formosa Optical Technology Co ROE % Related Terms


Formosa Optical Technology Co ROE % Historical Data

* Premium members only.

The historical data trend for Formosa Optical Technology Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Formosa Optical Technology Co ROE % Chart

Formosa Optical Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.05 6.50 15.06 15.39 10.70

Formosa Optical Technology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.24 13.60 5.49 19.11 7.05

ROCO:5312 vs ISRG, BDX, MDLN: ROE % Comparison

For the Medical Instruments & Supplies subindustry, Formosa Optical Technology Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Optical Technology Co ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Formosa Optical Technology Co's ROE % distribution charts can be found below:

* The bar in red indicates where Formosa Optical Technology Co's ROE % falls into.


ROCO:5312
82GF Score
Formosa Optical Technology Co Ltd ROCO:5312
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Formosa Optical Technology Co ROE % Calculation

Formosa Optical Technology Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=385.275/( (3472.91+3728.687)/ 2 )
=385.275/3600.7985
=10.70 %

Formosa Optical Technology Co's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=254.168/( (3483.807+3728.687)/ 2 )
=254.168/3606.247
=7.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 7.05% mean?
Formosa Optical Technology Co (ROCO:5312) has a ROE % of 7.05% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Formosa Optical Technology Co and its competitors. This is 44% below median its historical median of 12.64. Over the past decade, Formosa Optical Technology Co's ROE % has ranged from 6.50 to 15.80. According to the industry distribution chart, Formosa Optical Technology Co ranks #178 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 22.3%.
Is Formosa Optical Technology Co's ROE % too high?
Formosa Optical Technology Co's current ROE % of 7.05% is 44% below median its 10-year median of 12.64. Over the past 10 years, this metric has ranged from a low of 6.50 to a high of 15.80. The Medical Devices & Instruments industry median ROE % is 2.40. Formosa Optical Technology Co's value of 7.05% is 193.8% above this industry median. Based on the distribution chart, Formosa Optical Technology Co ranks #178 out of 797 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Formosa Optical Technology Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Formosa Optical Technology Co's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Formosa Optical Technology Co ranks #178 out of 797 companies for ROE %. This places Formosa Optical Technology Co in the top 22% of its industry — outperforming the majority of peers. The industry median ROE % is 2.40. Formosa Optical Technology Co's value of 7.05% is 193.8% above this benchmark. Historically, Formosa Optical Technology Co's own ROE % has ranged from 6.50 to 15.80 over the past decade. While the company's 10-year median is 12.64 vs. the industry median of 2.40, Formosa Optical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Formosa Optical Technology Co's current ROE % of 7.05% is 193.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Formosa Optical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Formosa Optical Technology Co's current ROE % is 7.05%, which is 44% below median its own 10-year median of 12.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formosa Optical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Formosa Optical Technology Co (ROCO:5312) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$108.56, compared to a current price of NT$88.10 — trading 18.8% below its estimated fair value. The current ROE % is 7.05%, which is 44% below median its 10-year median of 12.64 and 193.8% above the Medical Devices & Instruments industry median of 2.40. Formosa Optical Technology Co's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Formosa Optical Technology Co (ROCO:5312), the current ROE % is 7.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Formosa Optical Technology Co (ROCO:5312) Overvalued in 2026?

Based on GuruFocus' analysis, Formosa Optical Technology Co stock appears to be undervalued. The current stock price of NT$88.10 is trading 18.8% below its estimated GF Value™ of NT$108.56. GuruFocus considers Formosa Optical Technology Co to be Modestly Undervalued.

Key valuation signals for ROCO:5312:

  • ROE %: 7.05% (44% below median its 10-year median of 12.64)
  • GF Value™: NT$108.56 vs. price of NT$88.10 (18.8% below fair value)
  • GF Score™: 82/100 with 4 warning signs
  • Industry Position: 193.8% above the Medical Devices & Instruments median (#178 of 797)

No single metric tells the full story. See the ROCO:5312 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Formosa Optical Technology Co Business Description

Address No. 97, Xintai 5th Road, 16th Floor, Section 1, Xizhi District, New Taipei City, TWN
Formosa Optical Technology Co Ltd is mainly engaged in the eyewear business, including optometry services and the retail business selling contact lenses and eye drops. The Group mainly derives revenue from the business divisions of Formosa Optical Technology and Bo Wei Optical, with Formosa Optical Technology generating maximum revenue. The majority of revenue is derived from the sale of glasses. The Group generates the majority of its revenue from Taiwan.
82GF Score

Get the complete analysis for ROCO:5312

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$88.10
Price
NT$108.56
GF Value